Childhood adiposity trajectories and risk of nonalcoholic fatty liver disease in adolescents
- PMID: 24989077
- DOI: 10.1111/jgh.12666
Childhood adiposity trajectories and risk of nonalcoholic fatty liver disease in adolescents
Abstract
Background and aim: Nonalcoholic fatty liver disease (NAFLD) and its metabolic risk factors are recognized during childhood and adolescence. Identification of adolescents at risk of NAFLD from childhood anthropometry may expose opportunities to influence the hepatic and metabolic destinies of individuals. We sought associations between NAFLD diagnosed during adolescence and earlier life trajectories of anthropometry, in a population-based cohort of predominantly Caucasian adolescents.
Methods: Assessment for NAFLD, using questionnaires and liver ultrasound, was performed on 1170 adolescents, aged 17 years, from the population-based Raine cohort. We sought associations between NAFLD in adolescents and serial anthropometric measurements recorded from birth, childhood, and adolescence.
Results: NAFLD was diagnosed in 15.2% of adolescents. Birth anthropometry, including birth weight, skinfold thickness, and ponderal index, was not associated with NAFLD. However, adiposity differences between 17-year-old adolescents with NAFLD and those without NAFLD were apparent from age 3 years. Greater adiposity trajectories for weight, body mass index, skinfold thickness, mid-arm circumference, and chest circumference from age 3 years onwards, particularly in males, were associated with the diagnosis of NAFLD and severity of hepatic steatosis at age 17 years (P < 0.05). The strength of the associations increased with age after 3 years for each adiposity measure (all P < 0.001).
Conclusions: Trajectories of childhood adiposity are associated with NAFLD. Adiposity attained by 3 years of age and older, but not at birth, was associated with the diagnosis and severity of hepatic steatosis in late adolescence. Exploration of clinically relevant risk factors and preventative measures for NAFLD should begin during childhood.
Keywords: anthropometry; body mass index; cohort study; nonalcoholic fatty liver disease; skinfold thickness.
© 2014 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd.
Similar articles
-
Gender-specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease.Hepatology. 2011 Mar;53(3):800-9. doi: 10.1002/hep.24097. Hepatology. 2011. PMID: 21374659
-
Infant nutrition and maternal obesity influence the risk of non-alcoholic fatty liver disease in adolescents.J Hepatol. 2017 Sep;67(3):568-576. doi: 10.1016/j.jhep.2017.03.029. Epub 2017 Jun 12. J Hepatol. 2017. PMID: 28619255
-
Cord Blood Adipokines and Lipids and Adolescent Nonalcoholic Fatty Liver Disease.J Clin Endocrinol Metab. 2016 Dec;101(12):4661-4668. doi: 10.1210/jc.2016-2604. Epub 2016 Sep 20. J Clin Endocrinol Metab. 2016. PMID: 27648968 Free PMC article.
-
Comparison of the cardiometabolic profiles of adolescents conceived through ART with those of a non-ART cohort.Hum Reprod. 2022 Jul 30;37(8):1880-1895. doi: 10.1093/humrep/deac122. Hum Reprod. 2022. PMID: 35640037 Free PMC article.
-
Tackling Nonalcoholic Fatty Liver Disease: Three Targeted Populations.Hepatology. 2021 Mar;73(3):1199-1206. doi: 10.1002/hep.31533. Epub 2021 Feb 10. Hepatology. 2021. PMID: 32865242 Review. No abstract available.
Cited by
-
Determinants of non-alcoholic fatty liver disease in young people: Maternal, neonatal, and adolescent factors.PLoS One. 2024 Feb 22;19(2):e0298800. doi: 10.1371/journal.pone.0298800. eCollection 2024. PLoS One. 2024. PMID: 38386674 Free PMC article.
-
Urolithin C reveals anti-NAFLD potential via AMPK-ferroptosis axis and modulating gut microbiota.Naunyn Schmiedebergs Arch Pharmacol. 2023 Oct;396(10):2687-2699. doi: 10.1007/s00210-023-02492-8. Epub 2023 May 1. Naunyn Schmiedebergs Arch Pharmacol. 2023. PMID: 37126194
-
Development and validation of a novel non-invasive test for diagnosing nonalcoholic fatty liver disease in Chinese children.World J Pediatr. 2023 Apr 1. doi: 10.1007/s12519-023-00704-y. Online ahead of print. World J Pediatr. 2023. PMID: 37004681
-
Natural flavonoids: Potential therapeutic strategies for non-alcoholic fatty liver disease.Front Pharmacol. 2022 Sep 16;13:1005312. doi: 10.3389/fphar.2022.1005312. eCollection 2022. Front Pharmacol. 2022. PMID: 36188561 Free PMC article. Review.
-
Body composition trajectories from birth to 5 years and hepatic fat in early childhood.Am J Clin Nutr. 2022 Oct 6;116(4):1010-1018. doi: 10.1093/ajcn/nqac168. Am J Clin Nutr. 2022. PMID: 36055960 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
